Navigation Links
Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
Date:6/25/2013

New York, NY (PRWEB) June 25, 2013

On June 25, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the recent discovery of a combination of viruses that has proven to be effective against the deadliest forms of brain tumors.

According to an article on ScienceDaily.com, a combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor. This was reported by research performed by the Moffitt Cancer Center.

Peter A. Forsyth, M.D., of Moffitt’s Neuro-Oncology Program, says the combination “has been shown to infect and kill both brain cancer stem cells and differentiated compartments of glioblastoma multiforme.” This finding means that current barriers to treating the disease may be overcome. For example, some brain cancer patients experience drug resistance to existing therapies, which has become an obstacle in treatment. Forsyth says, “Oncolytic viruses that infect and break down cancer cells offer promising possibilities for overcoming resistance to targeted therapies.”

The authors of the study explain that the combination of viruses have the potential to start a “multipronged attack” on a tumor, with the possibility of killing cancer cells directly through viral infection and inducing the immune system to attack the tumor. There have been several oncolytic viruses that have been tested and show promise against malignant gliomas.

Forsyth says, “We found that myxoma virus combined with rapamycin is a potentially useful combination. The idea that cancer cells can be killed by a harmless virus is an exciting prospect for therapy.”

Michael Klipper, Chairman of Voic
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
2. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
3. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
4. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
5. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
6. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
7. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
8. Avatar therapy helps silence voices in schizophrenia
9. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
10. Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle
11. Voices Against Brain Cancer Commends Mother for the Way She Honors Her Daughter’s Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Ovarian cancer continues to be the deadliest ... getting ovarian cancer in her lifetime is approximately 1 in 75. This year it ... and 14,000 will die. , There is no test to detect ovarian cancer. ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich ... new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... business services, has been named to the Inc. 5000 List, an independent ... publishing this list for 34 years, and this achievement puts Canopy in rarefied ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an amazing ... and fauna. , Lifestyle Holidays Vacation Club knows that Puerto Plata ... experience that much better, Lifestyle Holidays Vacation Club has put together its list of ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... September ... about this disease that affects more than 233,000 men each year in the United ... is the most common non-skin cancer in America, affecting 1 in 7 men. One ...
Breaking Medicine News(10 mins):Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... in BJOG: An International Journal of Obstetrics and Gynaecology ... and placental abruption during the subsequent pregnancies of ... ,Placental praevia is defined as the implantation of ... the cervix. Placenta abruption is the premature separation of ...
... a campaign to encourage Hispanics to eat healthier food, ... U.S. Hispanics increased from 11.6% in 1991 to 23.7% ... obese and two times more likely to have diabetes ... ,LNC's campaign features a "Latin American ...
... their lives to work- related cancers and heart attacks can ... laws state that they no longer need to prove ... due the dead workers family. , The ... will be presumed to have been work-related when contracted by ...
... the US. A Defence Department panel has warned that ... serious challenge on two fronts. ,One, soldiers are ... at the current level of staffing and funds, the military ... necessary statement. ,In a damning revelation, the ...
... is no dearth of "anti-aging" products and surgeries in ... women go for them not just to enhance their looks, ... competitive enough in the market place, many observers point out. ... toxin. The toxin blocks the transmission of acetylcholine from the ...
... in 70 schoolchildren, available data says. The question is whether ... joint team of scientists from the King's College London ... up a seven-year study and hope to rope in 480 ... studied are between four and 11 months and already have ...
Cached Medicine News:Health News:Placental Problems in Women Linked With Caesarean Section 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2
(Date:9/1/2015)... Va. , Sept. 1, 2015  AccuTec Blades, ... Company,s (EPC) Industrial Blades division.  EPC announced in May ... in Verona, Virginia and ... completion of the sale process. ... Officer of AccuTec Blades said, "Our new name, AccuTec ...
(Date:9/1/2015)... and OR YEHUDA, Israel ... . (Nasdaq: HTWR ), a leading innovator of ... the treatment of advanced heart failure, announced today that ... Valtech Cardio, Ltd . ("Valtech").  Valtech is a ... innovative surgical and transcatheter valve repair and replacement devices ...
(Date:9/1/2015)... and BRUSSELS , Sept. ... and UCB (Euronext Brussels: UCB) today announced top-line ... of RomosozUmab Compared with Teriparatide in postmenopaUsal women ... treated with bisphosphonatE therapy). The study (NCT01796301) met ... in favor of romosozumab in the percent change ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... Sentry BioPharma Services , a ... management, prescription drug distribution and clinical packaging services, ... contract with the General Service Administration for inclusion ... Inclusion on this schedule will help Sentry BioPharma ...
... Reportlinker.com announces that a new market ... Gardasil (Cervical Cancer) - ... http://www.reportlinker.com/p0657236/Gardasil-Cervical-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Gardasil ... 2020 Summary ...
Cached Medicine Technology:Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X 2Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X 3Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020 2Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020 3Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020 4
Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance....
Inquire...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
Medicine Products: